Catheter Precision (VTAK) Operating Expenses (2017 - 2026)

Catheter Precision (VTAK) has 10 years of Operating Expenses data on file, last reported at $2.7 million in Q1 2026.

• Operating Expenses for Q1 2026 came in at $2.7 million, down 26.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $20.9 million (up 65.41% YoY), and the FY2025 annual result was $21.9 million, up 88.44% from the prior year.
• Operating Expenses eased to $2.7 million in Q1 2026 per VTAK's latest filing, from $10.1 million in the prior quarter.
• Over five years, Operating Expenses peaked at $66.6 million in Q1 2023 and troughed at $2.7 million in Q1 2024.
• A 5-year average of $8.3 million and a median of $3.7 million in 2025 frame the typical range for Operating Expenses.
• The sharpest annual moves came in 2023 and 2024: Operating Expenses soared 1128.71% in 2023, then plunged 95.95% in 2024.
• A 5-year view of Operating Expenses shows it stood at $8.2 million in 2022, then plunged by 66.91% to $2.7 million in 2023, then rose by 17.33% to $3.2 million in 2024, then surged by 216.06% to $10.1 million in 2025, then plunged by 73.13% to $2.7 million in 2026.
• Business Quant data shows VTAK's Operating Expenses at $2.7 million in Q1 2026, $10.1 million in Q4 2025, and $3.2 million in Q3 2025.